Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC)

Historical Holders from Q2 2020 to Q3 2025

Symbol
ORIC on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
98.5M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
106M
Holdings value
$1.28B
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
151
Number of buys
89
Number of sells
-56
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VIKING GLOBAL INVESTORS LP 9.99% +8.78% $95.1M $23.5M 8.73M +32.8% VIKING GLOBAL INVESTORS LP 30 Jun 2025
Nextech Crossover I GP S.a r.l. 8.4% $78.1M 7.16M Nextech Crossover I GP S.a. r.l. 30 Jun 2025
EcoR1 Capital, LLC 6.9% $73.3M 6.73M EcoR1 Capital, LLC 29 Jul 2025
Venrock Healthcare Capital Partners III, L.P. 7.7% +64% $35M $18.1M 6.6M +107% Venrock Healthcare Capital Partners III, L.P. 08 Apr 2025
SR ONE CAPITAL MANAGEMENT, LLC 4.75% -13% $50.3M 4.62M 0% SR One Capital Management, LLC 12 Aug 2025
ALKEON CAPITAL MANAGEMENT LLC 4.6% $54M 4.5M Alkeon Capital Management LLC 30 Sep 2025
Point72 Asset Management, L.P. 5.1% $23.4M 4.4M Point72 Asset Management, L.P. 29 May 2025
COLUMN GROUP II, LP 3.7% $48.6M 3.64M Peter Svennilson 30 Sep 2025
BlackRock, Inc. 4.2% $36.7M 3.62M BlackRock, Inc. 30 Jun 2025
FMR LLC 3.5% $14M 2.47M FMR LLC 31 Dec 2024
Frazier Life Sciences Public Fund, L.P. 2% $7.98M 1.41M James N. Topper 31 Mar 2025

Institutional Holders of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 106M $1.28B +$160M $12.00 151
2025 Q2 93.3M $947M +$170M $10.15 140
2025 Q1 79.2M $442M +$11.9M $5.58 142
2024 Q4 75.8M $612M -$16.3M $8.07 129
2024 Q3 69.8M $715M +$22.7M $10.25 121
2024 Q2 67.6M $478M +$20.2M $7.07 111
2024 Q1 63.9M $879M +$198M $13.75 110
2023 Q4 50.6M $466M +$34.7M $9.20 91
2023 Q3 48.1M $291M +$14.1M $6.05 89
2023 Q2 45.5M $353M +$99.1M $7.76 83
2023 Q1 33.1M $189M +$3.52M $5.70 70
2022 Q4 32.4M $192M +$136K $5.89 64
2022 Q3 32.7M $105M -$1.87M $3.20 69
2022 Q2 32.8M $147M -$6.22M $4.48 77
2022 Q1 33.9M $181M -$7.19M $5.34 94
2021 Q4 34.9M $512M -$36.8M $14.70 79
2021 Q3 31.5M $659M +$8.49M $20.91 78
2021 Q2 36.1M $639M +$2.95M $17.69 78
2021 Q1 35.7M $874M +$71.8M $24.50 82
2020 Q4 32.6M $1.1B +$273M $33.85 76
2020 Q3 22.2M $553M +$7.65M $25.01 53
2020 Q2 21.4M $718M +$718M $33.73 64